-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $212

Benzinga·10/01/2026 13:50:04
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $107 to $212.